published meta-analysis   sensitivity analysis   studies

Vitamins in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsEntrenas (Pilot Calcifediol), 2020 0.12 [0.01; 2.79] Jamali Moghadam Siahkali, 2021 1.00 [0.19; 5.40] Kumari, 2020 0.60 [0.22; 1.64] 0.61[0.26; 1.40]Entrenas (Pilot Calcifediol), 2020, Jamali Moghadam Siahkali, 2021, Kumari, 202030%286lownot evaluable mechanical ventilationdetailed resultsJamali Moghadam Siahkali, 2021 1.30 [0.31; 5.40] Kumari, 2020 0.76 [0.33; 1.76] 0.87[0.42; 1.80]Jamali Moghadam Siahkali, 2021, Kumari, 202020%210lownot evaluable ICU admissiondetailed resultsEntrenas (Pilot Calcifediol), 2020 0.03 [0.00; 0.27] 0.03[0.00; 0.27]Entrenas (Pilot Calcifediol), 202010%76NAnot evaluable0.02.01.0relative treatment effectwww.metaEvidence.org2024-05-27 09:11 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 1244,523,885,734,1439 - roots T: 290